Paper17174271
Antimalarial properties of green tea.
Sannella AR and 6 others. Biochem Biophys Res Commun, 2007. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Antimalarial properties of green tea. Papers, record 17174271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17174271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Catechin | Major topic |
| Plant Extracts | Major topic |
| Plasmodium falciparum | Major topic |
| Tea | Major topic |
| Animals | |
| Antimalarials | |
| Dose-Response Relationship, Drug |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41737453 | Isolation and characterization of antiplasmodial and antimicrobial compounds from Tetracera alnifolia using a bioassay-guided approach. | RSC Adv | 2026 | https://conductscience.org/library/papers/41737453 | PubMed |
| 41596863 | From Forestry By-Product to Functional Food Ingredient Innovation: Antiproliferative, Antimetastatic and Antiplasmodial Activities of Norway Spruce Sawdust Extract. | Foods | 2026 | https://conductscience.org/library/papers/41596863 | PubMed |
| 36271358 | The protein aggregation inhibitor YAT2150 has potent antimalarial activity in Plasmodium falciparum in vitro cultures. | BMC Biol | 2022 | https://conductscience.org/library/papers/36271358 | PubMed |
| 36249737 | In Vivo Antimalarial Activity of the Leaf Extract of Osyris quadripartita Salzm. ex Decne and Its Major Compound (-) Catechin. | J Trop Med | 2022 | https://conductscience.org/library/papers/36249737 | PubMed |
| 35488142 | Plants as Sources of Natural and Recombinant Antimalaria Agents. | Mol Biotechnol | 2022 | https://conductscience.org/library/papers/35488142 | PubMed |
| 35445447 | An overview of the Plasmodium falciparum hexose transporter and its therapeutic interventions. | Proteins | 2022 | https://conductscience.org/library/papers/35445447 | PubMed |
| 32512260 | In vitro activity of Camellia sinensis (green tea) against trophozoites and cysts of Acanthamoeba castellanii. | Int J Parasitol Drugs Drug Resist | 2020 | https://conductscience.org/library/papers/32512260 | PubMed |
| 32499668 | Antiplasmodial activity of Cocos nucifera leaves in Plasmodium berghei-infected mice. | J Parasit Dis | 2020 | https://conductscience.org/library/papers/32499668 | PubMed |
| 31805944 | Antiplasmodial natural products: an update. | Malar J | 2019 | https://conductscience.org/library/papers/31805944 | PubMed |
| 30607316 | Molecular docking and ADME properties of bioactive molecules against human acid-beta-glucosidase enzyme, cause of Gaucher's disease. | In Silico Pharmacol | 2018 | https://conductscience.org/library/papers/30607316 | PubMed |
| 29333044 | Antiplasmodial Activity of Isolated Polyphenols from Alectryon serratus Leaves Against 3D7 Plasmodium falciparum. | Pharmacognosy Res | 2017 | https://conductscience.org/library/papers/29333044 | PubMed |
| 29206141 | (-)-Epigallocatechin-3-Gallate Inhibits the Chaperone Activity of Plasmodium falciparum Hsp70 Chaperones and Abrogates Their Association with Functional Partners. | Molecules | 2017 | https://conductscience.org/library/papers/29206141 | PubMed |
| 28388918 | Tea (Camellia sinensis) infusions ameliorate cancer in 4TI metastatic breast cancer model. | BMC Complement Altern Med | 2017 | https://conductscience.org/library/papers/28388918 | PubMed |
| 27659310 | Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans. | BMC Oral Health | 2016 | https://conductscience.org/library/papers/27659310 | PubMed |
| 22973133 | Cytoadherence and severe malaria. | Malays J Med Sci | 2012 | https://conductscience.org/library/papers/22973133 | PubMed |
| 22315700 | Medicinal plants used by various tribes of bangladesh for treatment of malaria. | Malar Res Treat | 2012 | https://conductscience.org/library/papers/22315700 | PubMed |
| 21842382 | Evaluation of medicinal plant extracts and isolated compound epicatechin from Ricinus communis against Paramphistomum cervi. | Parasitol Res | 2012 | https://conductscience.org/library/papers/21842382 | PubMed |
| 21676209 | Plasmodial sugar transporters as anti-malarial drug targets and comparisons with other protozoa. | Malar J | 2011 | https://conductscience.org/library/papers/21676209 | PubMed |
| 21411015 | Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions. | Malar J | 2011 | https://conductscience.org/library/papers/21411015 | PubMed |
| 20657468 | Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artemisinin against malaria and cancer. | Molecules | 2010 | https://conductscience.org/library/papers/20657468 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17174271
GET https://conductscience.org/api/papers/v1/17174271/cited_by?page=2